By Kelly Cloonan
Kestra Medical Technologies posted higher revenue in its fiscal third quarter, in its first quarterly results since going public.
The wearable medical device company posted a loss of $21.5 million, or $1.25 a share, for the quarter ended Jan. 31, compared with a loss of $21.6 million, or $1.18 a share, a year earlier.
Revenue rose 82% to $15.1 million, in line with analyst estimates, compared with $8.3 million a year ago.
New account activations and a higher wallet share at existing customers drove the revenue growth, the company said. A higher mix of in-network patients and improvements in revenue cycle management capabilities also helped boost sales.
For fiscal 2025, Kestra expects revenue of $58 million to $58.5 million, in line with analyst estimates of $58.2 million.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
April 14, 2025 16:40 ET (20:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。